Skip to main content

Table 2 Results of CCL18 and A1AT in experimental hematuria model

From: Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection

Dilution (volume of whole blood)

Red blood cells ( /hpf * )

Concentration (mean ± SD)

Urinary protein (dipstick test)

Hemoglobin (ng/ml)

CCL18 (pg/ml)

A1AT (ng/ml)

0

0 ± 0

3.63 ± 0.59

5.96 ± 7.73

1170.70 ± 71.94

negative

1/10,000 (1 μl)

0.6 ± 1.0

174.28 ± 15.69

7.06 ± 7.78

1227.31 ± 1.22

negative

1/2,000 (5 μl)

2.4 ± 1.2

2289.34 ± 479.07

6.80 ± 9.61

1252.49 ± 2.92

30 mg/dL

1/500 (20 μl)

10.0 ± 4.4

3633.39 ± 2006.87

16.62 ± 22.17

1258.43 ± 13.48

100 mg/dL

1/200 (50 μl)

17.3 ± 3.0

7898.05 ± 184.67

31.90 ± 43.19

1273.16 ± 5.53

300 mg/dL

  1. *hpf high power field.